SCHEMBL16626440

SCHEMBL16626440

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3cc(C)ccc3F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.37
CYP19A1 P11511 1/20 0.37
IDE P14735 1/20 0.36
CDK4 P11802 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
HTR6 P50406 6/20 0.35
ALK Q9UM73 2/20 0.34
AURKA O14965 1/20 0.34
MAPK13 O15264 1/20 0.34
DYRK3 O43781 1/20 0.34
ROCK2 O75116 1/20 0.34
RPS6KA5 O75582 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
LCK P06239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618761 0.99 NAMPT (0.37) NAMPTCYP19A1IDECDK4CCNE1
SCHEMBL16626413 0.93 NAMPT (0.37) NAMPTCYP19A1IDEPDE4APDE4B
Hydrochloric Acid SCHEMBL16619306 0.92 NAMPT (0.37) NAMPTCYP19A1IDEPDE4APDE4B
SCHEMBL17971527 0.92 MAP2K7 (0.38) NAMPTIDEHTR6HTTCHRNB2
Hydrochloric Acid SCHEMBL16619280 0.92 MAP2K4 (0.38) NAMPTIDEHTR6HTTCHRNB2
SCHEMBL16626680 0.91 CHRNB2 (0.41) NAMPTCYP19A1IDEHTR6HTT
SCHEMBL16626700 0.91 IDE (0.38) CYP19A1IDEPDE4APDE4BPDE4C
SCHEMBL16626446 0.90 IDE (0.36) NAMPTCYP19A1IDEPDE4APDE4B
SCHEMBL16626462 0.90 IDE (0.38) NAMPTCYP19A1IDEPDE4APDE4B
Hydrochloric Acid SCHEMBL16619175 0.90 IDE (0.37) CYP19A1IDEPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI NAMPT 1610/4885CYP19A1 3808/4885IDE 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.